Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer's Disease

Nikita Navolokin,Viktoria Adushkina,Daria Zlatogorskaya,Valeria Telnova,Arina Evsiukova,Elena Vodovozova,Anna Eroshova,Elina Dosadina,Sergey Diduk,Oxana Semyachkina-Glushkovskaya
DOI: https://doi.org/10.3390/ph17060788
IF: 4.6
2024-06-17
Pharmaceuticals
Abstract:The COVID-19 pandemic, caused by infection with the SARS-CoV-2 virus, is associated with cognitive impairment and Alzheimer's disease (AD) progression. Once it enters the brain, the SARS-CoV-2 virus stimulates accumulation of amyloids in the brain that are highly toxic to neural cells. These amyloids may trigger neurological symptoms in COVID-19. The meningeal lymphatic vessels (MLVs) play an important role in removal of toxins and mediate viral drainage from the brain. MLVs are considered a promising target to prevent COVID-19-exacerbated dementia. However, there are limited methods for augmentation of MLV function. This review highlights new discoveries in the field of COVID-19-mediated amyloid accumulation in the brain associated with the neurological symptoms and the development of promising strategies to stimulate clearance of amyloids from the brain through lymphatic and other pathways. These strategies are based on innovative methods of treating brain dysfunction induced by COVID-19 infection, including the use of photobiomodulation, plasmalogens, and medicinal herbs, which offer hope for addressing the challenges posed by the SARS-CoV-2 virus.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The problems that this paper attempts to solve are: how does the SARS - CoV - 2 virus cause amyloid deposition in the brain, and how do these deposits lead to or exacerbate Alzheimer's disease (AD) and other forms of dementia. Specifically, the paper explores the following points: 1. **The relationship between the SARS - CoV - 2 virus and amyloid deposition**: After entering the brain, the SARS - CoV - 2 virus will stimulate the accumulation of amyloid proteins. These amyloid proteins are highly toxic to nerve cells and may cause COVID - 19 - related neurological symptoms. 2. **The role of meningeal lymphatic vessels (MLVs)**: MLVs play an important role in removing toxins and viruses from the brain. The paper discusses methods to enhance the function of MLVs to prevent dementia exacerbated by COVID - 19. 3. **Potential treatment strategies**: The paper reviews a variety of innovative methods aimed at removing amyloid proteins from the brain through the lymphatic system and other pathways, including photobiomodulation, plasmalogens, and the use of medicinal plants. ### Key point summary - **Structural proteins of the SARS - CoV - 2 virus**: The spike protein, nucleocapsid protein, and accessory proteins ORF6/ORF10 of the SARS - CoV - 2 virus all contain amyloid - forming sequences. These proteins will replicate in large quantities after infecting cells and form amyloid deposits inside and outside the cells. - **The impact of amyloid deposition in the brain**: The SARS - CoV - 2 virus causes the accumulation of amyloid proteins in the brain by binding to Aβ (amyloid - β protein) and forming its own amyloid proteins, which in turn leads to memory impairment and other neurological symptoms. - **The function of MLVs**: MLVs play a crucial role in removing amyloid proteins and other toxins from the brain. Enhancing the function of MLVs may help prevent or slow down the development of AD. - **Treatment strategies**: The paper proposes some potential treatment methods, such as photobiomodulation, plasmalogen supplementation, and the use of natural compounds. These methods may help reduce amyloid deposition in the brain and improve cognitive function. In conclusion, this paper aims to propose effective prevention and treatment strategies by exploring the mechanism of amyloid deposition in the brain caused by the SARS - CoV - 2 virus, so as to reduce the impact of COVID - 19 on cognitive function.